Dr. Reddy's Laboratories
RDY
#1699
Rank
A$17.86 B
Marketcap
A$21.36
Share price
0.35%
Change (1 day)
-4.18%
Change (1 year)

Dr. Reddy's Laboratories (RDY) - Cash on Hand

Cash on Hand as of September 2025 : A$1.18 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company has A$1.18 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Dr. Reddy's Laboratories - Cash on Hand chart (from 2001 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-03-31A$1.08 B-27.44%
2024-03-31A$1.49 B33.19%
2023-03-31A$1.12 B43.97%
2022-03-31A$0.78 B25.44%
2021-03-31A$0.62 B11.69%
2020-03-31A$0.55 B11.09%
2019-03-31A$0.50 B19.57%
2018-03-31A$0.41 B14.63%
2017-03-31A$0.36 B-53.49%
2016-03-31A$0.78 B-5.93%
2015-03-31A$0.83 B38.6%
2014-03-31A$0.60 B54.24%
2013-03-31A$0.39 B13.7%
2012-03-31A$0.34 B174.17%
2011-03-31A$0.12 B-49.42%
2010-03-31A$0.24 B43.04%
2009-03-31A$0.17 B-47.43%
2008-03-31A$0.32 B-36.22%
2007-03-31A$0.51 B337.92%
2006-03-31A$0.11 B-58.65%
2005-03-31A$0.28 B34.74%
2004-03-31A$0.21 B-16.14%
2003-03-31A$0.25 B29%
2002-03-31A$0.19 B825.6%
2001-03-31A$21.17 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Pfizer
PFE
A$22.55 B 1,806.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$3.31 B 180.35%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
A$6.69 B 465.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
A$14.68 B 1,141.16%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
A$15.73 B 1,230.10%๐Ÿ‡ซ๐Ÿ‡ท France